Drug Database
Back to search

Poland· PL-100518171

Phytomenadione BB Pharma

A phytomenadione product containing int-rac-phytomenadionum, registered in Poland by BB Pharma a.s.. The same ATC class is registered in 15 of our 19 countries.

ATC B02BA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPhytomenadione BB PharmaATCB02BA01REGISTER NO.PL-100518171PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about int-rac-phytomenadionumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Phytomenadione is registered in 15 of 19 countries.

Countries holding a registration under ATC B02BA01 (phytomenadione), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search phytomenadione products by name

Phytomenadione · ATC B02BA01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
int-rac-Phytomenadionum
Manufacturer
BB Pharma a.s.
Country
Poland (PL)
ATC code
B02BA01
ATC class
Phytomenadione
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    08588001339937
  • gtin
    08588001339920

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

188 interactions on record for phytomenadione.

Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check phytomenadione against other medicinesHow interaction checks work

Phytomenadione · interactions on record

188 records

  • 6 moderate
  • 2 minor
  • 180 info

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • ColestyramineC10AC01moderate
  • ColestipolC10AC02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Phytomenadione in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phytomenadione products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Konakion
  • Belgium · Konakion, Konakion Paediatric
  • Cyprus · Kanavit
  • Czechia · Kanavit
  • Germany · Ka-Vit Tropfen, Konakion
  • Denmark · Konakion Novum, Menadion Scanpharm
  • Spain · Konakion, Konakion Pediátrico
  • Finland · Konakion Novum
  • France · Vitamine K1 Cheplapharm, Vitamine K1 Nourrissons Cheplapharm
  • United Kingdom (Northern Ireland) · Konakion Mm Ampoules, Konakion Mm Paediatric
  • Croatia · Konakion Mm
  • Hungary · Konakion
  • Ireland · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
  • Italy · Konakion, Konakion Prima Infanzia
  • Malta · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
  • Netherlands · Konakion Mixed Micelles, Konakion Mm Voor Kinderen
  • Norway · Konakion
  • Portugal · Kanakion Mm, Kanakion Mm Pediátrico
  • Romania · Fitomenadion Terapia
  • Sweden · Konakion
  • Slovakia · Kanavit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8e53e71f-45bb-49f4-9e4b-5097ff568bda
GET /v1/drugs/8e53e71f-45bb-49f4-9e4b-5097ff568bda?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsja do wstrzykiwań",
  "source": "urpl",
  "strength": "10 mg/ml",
  "packaging": "08588001339937 ¦ Rp ¦ 167048\n5 amp. 1 ml\n08588001339920 ¦ Rp ¦ 167049\n10 amp. 1 ml",
  "substance": "int-rac-Phytomenadionum 10 mg/ml",
  "common_name": "int-rac-Phytomenadionum",
  "pl_product_id": "100518171",
  "pozwolenie_nr": "29631",
  "auth_procedure": "MRP",
  "authorisation_validity": "2031-04-09"
}
API referenceMCP serverPlans

See everything about phytomenadione.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console